Generics

Lupin is launching generic Onfi, which had a market value of $253 million.

Camber's generic Detrol LA is available in two dosage strengths.

Dr. Reddy's is introducing generic Adcirca, which had a market value of roughly $490 million.

Methocarbamol injection is used to provide relief for acute, painful musculoskeletal conditions.

Lupin has received the FDA's nod for generic fluoxetine, which had a market value of roughly $42.5 million for the year ended December 2018.

The Association for Accessible Medicines has told members of Congress that the Hatch-Waxman Integrity Act of 2019 would decrease patient access to generics and biosimilars.

Teva's generic of Eli Lilly's Adcirca is indicated to treat pulmonary arterial hypertension.

The Food and Drug Administration has cleared Lupin's generic Adcirca, which had a market value of about $474.3 million for the year ended December 2018.